• 
• http://www.nature.com/nbt/
• Editor: Andrew Marshall
• Volume 26: 12 issues per year
• ISSN: 1087-0156
• EISSN: 1546-1696
• Impact factor : 22.848*
• Impact ranking: 2/138 in Biotechnology & Applied Microbiology*
• Date Established: March 1996
• Published on behalf of:

No. 1 primary research journal in Biotechnology and Applied Microbiology

Aims and Scope:
Nature Biotechnology is a monthly journal covering the science and business of biotechnology. It publishes applied research of relevance to the biological, biomedical, agricultural and environmental sciences as well as covers the commercial, political, ethical, legal and societal aspects of this research.

Nature Biotechnology has the highest impact factor of primary research journals in the category of biotechnology and applied microbiology, and its ever-growing number of citations is evidence of the influence and authority of its articles, authors and readers.

Readership
Nature Biotechnology's primary audience is researchers in academia, industry and government interested in biological applied research and new technology. Nature Biotechnology's readers also work in industry regulation, the financial and investment community and the legal community.

Online features and site license access:

• Online archive available back to March 1983, including all issues of Bio/Technology.
• A site license provides access to all content published during the supply period. Access is granted to a further rolling four-year archive during the supply period only. Archive content not included in the license agreement is available to purchase.
• Special web focus issues have included Antibacterials and Antivirals.
• Users benefit from all the online features outlined on pages 6-9.
• Indexed in BIOBASE, BIOSIS, CAS, CSA, CAB Abstracts, EMBASE, Scopus, Current Contents, Science Citation Index and Medline (PubMed).

*2007 Journal Citation Report (Thomson Reuters, 2008)